Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian E Alexander

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
Human Gene Therapy|July 9, 2021
Adeno-Associated Virus Vector Gene Delivery Elevates Factor I Levels and Downregulates the Complement Alternative Pathway <i>In Vivo</i>Amina Ahmad, Mawj Mandwie, Anna K Dreismann, et al.
Circulation Research|May 15, 2007
Gene transfer of connexin43 mutants attenuates coupling in cardiomyocytes: novel basis for modulation of cardiac conduction by gene therapyEddy Kizana, Connie Y Chang, Eugenio Cingolani, et al.
Molecular Therapy. Methods & Clinical Development|October 27, 2021
Safety and efficacy of an engineered hepatotropic AAV gene therapy for ornithine transcarbamylase deficiency in cynomolgus monkeysJulien Baruteau, Sharon C Cunningham, Berna Seker Yilmaz, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 30, 2011
A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cellsJad El-Hoss, Kate Sullivan, Tegan Cheng, et al.
Human Gene Therapy|March 16, 2022
Conversion of the Liver into a Biofactory for DNaseI Using Adeno-Associated Virus Vector Gene Transfer Reduces Neutrophil Extracellular Traps in a Model of Systemic Lupus ErythematosusAmina Ahmad, Mawj Mandwie, Kim M O'Sullivan, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Structural characterization of antibody-responses from Zolgensma treatment provides the blueprint for the engineering of an AAV capsid suitable for redosingMario Mietzsch, Austin R Nelson, Jane Hsi, et al.
Molecular Therapy. Methods & Clinical Development|June 7, 2021
Single amino acid insertion allows functional transduction of murine hepatocytes with human liver tropic AAV capsidsMarti Cabanes-Creus, Renina Gale Navarro, Sophia H Y Liao, et al.
The Journal of Gene Medicine|March 27, 2018
Partial pancreatic transdifferentiation of primary human hepatocytes in the livers of a humanised mouse modelBinhai Ren, Que T La, Bronwyn A O'Brien, et al.
Human Gene Therapy|July 21, 2018
Age-Related Seroprevalence of Antibodies Against AAV-LK03 in a UK Population CohortDany P Perocheau, Sharon Cunningham, Juhee Lee, et al.
Clinical and Experimental Immunology|March 11, 2026
A novel fusion protein reduces kidney complement in experimental C3 glomerulopathyTalat H Malik, Karolina Kwiatkowska, Hannah J Lomax-Browne, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Human Gene Therapy|July 9, 2021
Adeno-Associated Virus Vector Gene Delivery Elevates Factor I Levels and Downregulates the Complement Alternative Pathway <i>In Vivo</i>Amina Ahmad, Mawj Mandwie, Anna K Dreismann, et al.
Circulation Research|May 15, 2007
Gene transfer of connexin43 mutants attenuates coupling in cardiomyocytes: novel basis for modulation of cardiac conduction by gene therapyEddy Kizana, Connie Y Chang, Eugenio Cingolani, et al.
Molecular Therapy. Methods & Clinical Development|October 27, 2021
Safety and efficacy of an engineered hepatotropic AAV gene therapy for ornithine transcarbamylase deficiency in cynomolgus monkeysJulien Baruteau, Sharon C Cunningham, Berna Seker Yilmaz, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 30, 2011
A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cellsJad El-Hoss, Kate Sullivan, Tegan Cheng, et al.
Human Gene Therapy|March 16, 2022
Conversion of the Liver into a Biofactory for DNaseI Using Adeno-Associated Virus Vector Gene Transfer Reduces Neutrophil Extracellular Traps in a Model of Systemic Lupus ErythematosusAmina Ahmad, Mawj Mandwie, Kim M O'Sullivan, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Structural characterization of antibody-responses from Zolgensma treatment provides the blueprint for the engineering of an AAV capsid suitable for redosingMario Mietzsch, Austin R Nelson, Jane Hsi, et al.
Molecular Therapy. Methods & Clinical Development|June 7, 2021
Single amino acid insertion allows functional transduction of murine hepatocytes with human liver tropic AAV capsidsMarti Cabanes-Creus, Renina Gale Navarro, Sophia H Y Liao, et al.
The Journal of Gene Medicine|March 27, 2018
Partial pancreatic transdifferentiation of primary human hepatocytes in the livers of a humanised mouse modelBinhai Ren, Que T La, Bronwyn A O'Brien, et al.
Human Gene Therapy|July 21, 2018
Age-Related Seroprevalence of Antibodies Against AAV-LK03 in a UK Population CohortDany P Perocheau, Sharon Cunningham, Juhee Lee, et al.
Clinical and Experimental Immunology|March 11, 2026
A novel fusion protein reduces kidney complement in experimental C3 glomerulopathyTalat H Malik, Karolina Kwiatkowska, Hannah J Lomax-Browne, et al.
Pageof 14